Insulin suppresses the production of fibroblast growth factor 23 (FGF23)

FOXO1 cysteine-612 mediates stimulatory effects of the coregulators CBP and PGC1α on FOXO1 basal transcriptional activity

(2018) Dimitrios Tsitsipatis et al.   FREE RADICAL BIOLOGY AND MEDICINE

The transcription factor Foxo1 controls germinal center B cell proliferation in response to T cell help

(2017) Takeshi Inoue et al.   JOURNAL OF EXPERIMENTAL MEDICINE

Longitudinal FGF23 Trajectories and Mortality in Patients with CKD

(2017) Tamara Isakova et al.   JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY

Klotho expression in osteocytes regulates bone metabolism and controls bone formation

(2017) Hirotaka Komaba et al.   KIDNEY INTERNATIONAL

The complexity of chronic kidney disease–mineral and bone disorder across stages of chronic kidney disease

(2017) Fabiana G. Graciolli et al.   KIDNEY INTERNATIONAL

FOXO1 opposition of CD8+T cell effector programming confers early memory properties and phenotypic diversity

(2017) Arnaud Delpoux et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Soluble klotho binds monosialoganglioside to regulate membrane microdomains and growth factor signaling

(2017) George Dalton et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

The production of fibroblast growth factor 23 is controlled by TGF-β2

(2017) Martina Feger et al.   Scientific Reports

The effect of GH treatment on serum FGF23 and Klotho in GH-deficient children

(2016) Alexandra Efthymiadou et al.   EUROPEAN JOURNAL OF ENDOCRINOLOGY

Enhanced FGF23 production in mice expressing PI3K-insensitive GSK3 is normalized by β-blocker treatment

(2016) Abul Fajol et al.   FASEB JOURNAL

Genetic Evidence for Causal Relationships Between Maternal Obesity-Related Traits and Birth Weight

(2016) Jessica Tyrrell et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Maternal PCaaC38:6 is Associated With Preterm Birth - a Risk Factor for Early and Late Adverse Outcome of the Offspring

(2016) Jian Li et al.   KIDNEY & BLOOD PRESSURE RESEARCH

Inflammation and functional iron deficiency regulate fibroblast growth factor 23 production

(2016) Valentin David et al.   KIDNEY INTERNATIONAL

PI3K-resistant GSK3 controls adiponectin formation and protects from metabolic syndrome

(2016) Hong Chen et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Elevation in fibroblast growth factor 23 and its value for identifying subclinical atherosclerosis in first-degree relatives of patients with diabetes

(2016) Xiang Hu et al.   Scientific Reports

FGF23 in Acute and Chronic Illness

(2015) Christian Schnedl et al.   DISEASE MARKERS

NFκB-sensitive Orai1 expression in the regulation of FGF23 release

(2015) Bingbing Zhang et al.   JOURNAL OF MOLECULAR MEDICINE-JMM

Associations of Fibroblast Growth Factor-23 with Markers of Inflammation, Insulin Resistance and Obesity in Adults

(2015) Lynae J. Hanks et al.   PLoS One

FGF23 in Type 2 Diabetic Patients: Relationship With Bone Metabolism and Vascular Disease

(2014) Rebeca Reyes-Garcia et al.   DIABETES CARE

Growth Hormone, Insulin-Like Growth Factor-1, and the Kidney: Pathophysiological and Clinical Implications

(2014) Peter Kamenický et al.   ENDOCRINE REVIEWS

Renal expression of FGF23 and peripheral resistance to elevated FGF23 in rodent models of polycystic kidney disease

(2014) Daniela Spichtig et al.   KIDNEY INTERNATIONAL

PI3K and cancer: lessons, challenges and opportunities

(2014) David A. Fruman et al.   NATURE REVIEWS DRUG DISCOVERY

Insulin resistance is associated with Fibroblast Growth Factor-23 in stage 3–5 chronic kidney disease patients

(2013) Jocelyn S. Garland et al.   JOURNAL OF DIABETES AND ITS COMPLICATIONS

FOXOs: signalling integrators for homeostasis maintenance

(2013) Astrid Eijkelenboom et al.   NATURE REVIEWS MOLECULAR CELL BIOLOGY

Klotho, phosphate and FGF-23 in ageing and disturbed mineral metabolism

(2013) Makoto Kuro-o   Nature Reviews Nephrology

1,25-Dihydroxyvitamin D3 Regulation of Fibroblast Growth Factor-23 Expression in Bone Cells: Evidence for Primary and Secondary Mechanisms Modulated by Leptin and Interleukin-6

(2012) Rimpi K. Saini et al.   CALCIFIED TISSUE INTERNATIONAL

Anti-Inflammatory Therapy in Type 1 Diabetes

(2012) Bernd Baumann et al.   Current Diabetes Reports

Earlier Onset and Greater Severity of Disordered Mineral Metabolism in Diabetic Patients With Chronic Kidney Disease

(2012) P. Wahl et al.   DIABETES CARE

Uric acid and IGF1 as possible determinants of FGF23 metabolism in children with normal renal function

(2012) Justine Bacchetta et al.   PEDIATRIC NEPHROLOGY

Loss of insulin-induced activation of TRPM6 magnesium channels results in impaired glucose tolerance during pregnancy

(2012) A. V. Nair et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Fibroblast growth factor 23 is associated with proteinuria and smoking in chronic kidney disease: An analysis of the MASTERPLAN cohort

(2012) Marc G Vervloet et al.   BMC Nephrology

FGF23 induces left ventricular hypertrophy

(2011) Christian Faul et al.   JOURNAL OF CLINICAL INVESTIGATION

Changes in plasma FGF23 in growth hormone deficient children during rhGH therapy

(2011) James Gardner et al.   JOURNAL OF PEDIATRIC ENDOCRINOLOGY & METABOLISM

PKB/SGK-Resistant GSK3 Enhances Phosphaturia and Calciuria

(2011) M. Foller et al.   JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY

Decreased bone density and increased phosphaturia in gene-targeted mice lacking functional serum- and glucocorticoid-inducible kinase 3

(2011) Madhuri Bhandaru et al.   KIDNEY INTERNATIONAL

Acute hyperinsulinemia is followed by increased serum concentrations of fibroblast growth factor 23 in type 2 diabetes patients

(2011) Kristian Winther et al.   SCANDINAVIAN JOURNAL OF CLINICAL & LABORATORY INVESTIGATION